Perspectives in evaluating the safety and effectiveness of steroidal contraceptives in different parts of the world.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 923897)

Published in Int J Gynaecol Obstet on January 01, 1977

Authors

J W Goldzieher

Articles citing this

Infective causes of stroke in tropical regions. Iran J Med Sci (2012) 1.05

Articles by these authors

(truncated to the top 100)

A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil Steril (1971) 1.89

Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. J Reprod Med (1983) 1.45

Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol (1985) 1.36

Study of norethindrone in contraception. JAMA (1962) 1.26

Return of ovulation after discontinuance of oral contraceptives. Fertil Steril (1967) 1.13

Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstet Gynecol (1985) 1.07

Spectrum of nonpuerperal galactorrhea: report of two cases evolving through the various syndromes. J Clin Endocrinol Metab (1967) 1.05

Improving the diagnostic reliability of rapidly fluctuating plasma hormone levels by optimized multiple-sampling techniques. J Clin Endocrinol Metab (1976) 1.03

Morphology of the cervix in women treated with synthetic progestins. Am J Obstet Gynecol (1966) 0.92

Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. Am J Obstet Gynecol (1971) 0.91

Oral contraceptive hazards--1981. Fertil Steril (1981) 0.90

Fertility control with long-acting injectable steroids. A preliminary report. Obstet Gynecol (1966) 0.90

American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract (2003) 0.89

The urinary metabolites of 17alpha-ethynylestradiol-9alpha,11xi-3H in women. Chromatographic profiling and indentification of ethynyl and non-ethynyl compounds. Steroids (1975) 0.89

Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations. Steroids (1980) 0.88

Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives. Am J Obstet Gynecol (1970) 0.88

Polycystic ovarian disease. Fertil Steril (1981) 0.88

Plasma levels and pharmacokinetics of ethynyl estrogens in various populations: II. Mestranol. Contraception (1980) 0.88

Human urinary and liver conjugates of 17alpha-ethnylestradiol. Steroids (1976) 0.87

Gross Cerebral Hemorrhage and Vascular Lesions in Acute Tuberculous Meningitis and Meningo-Encephalitis. Am J Pathol (1947) 0.87

Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol. Contraception (1980) 0.87

Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower? Contraception (1989) 0.86

The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. Am J Obstet Gynecol (1983) 0.85

Pharmacokinetics of ethynyloestradiol in women for different populations. Contraception (1981) 0.85

Relation of parity to age at menopause. Am J Obstet Gynecol (1966) 0.85

Urinary excretion of gonadotropins in congenital adrenal hyperplasia. Pediatrics (1968) 0.85

Metabolism of ethynyl estrogens. J Toxicol Environ Health (1977) 0.84

Oral contraceptives and thromboembolism: a reassessment. Am J Obstet Gynecol (1975) 0.83

The polycystic ovary. VI. A hilus cell tumour of the ovary associated with polycystic ovarian disease: in vivo and in vitro studies. Acta Endocrinol (Copenh) (1966) 0.83

The pharmacokinetics of ethynyl estrogens. A review. Contraception (1977) 0.82

Polycystic ovarian disease. Clin Obstet Gynecol (1973) 0.82

Induction of degenerative changes in uterine myomas by high-dosage progestin therapy. Am J Obstet Gynecol (1966) 0.82

Hormone-induced alterations of ovarian morphology. Fertil Steril (1966) 0.82

Plasma androgens during early pregnancy in the baboon (Papio cynocephalus). Fertil Steril (1983) 0.81

Pharmacokinetics of ethynyl estradiol: a current view. Contraception (1985) 0.80

Induction of ovulation and term pregnancy in a hypophysectomized woman. A case report. Obstet Gynecol (1972) 0.80

Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency. Am J Obstet Gynecol (1975) 0.79

Inhibition by adrenocorticotrophin of gonadotrophin-induced ovulation in immature female rats. Endocrinology (1969) 0.79

The mechanism of ovulation inhibition by triamcinolone acetonide. J Clin Endocrinol Metab (1978) 0.79

Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Fertil Steril (1978) 0.79

A simplified gas chromatographic method for large numbers of urinary pregnanediol determinations. Am J Obstet Gynecol (1967) 0.79

Physiological cost in 36-and 48-hour simulated flights. Aerosp Med (1973) 0.78

The metabolism of [4-14C] progesterone by hypertrophic and carcinomatous human prostate tissue. Biochim Biophys Acta (1965) 0.78

Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles. Obstet Gynecol (1986) 0.78

The relationship of estrogen to placental steroidogenesis in the baboon. J Clin Endocrinol Metab (1986) 0.78

The polycystic ovary. V. Alternate pathways of steroid aromatization in normal, pregnancy and polycystic ovaries. J Clin Endocrinol Metab (1965) 0.78

Estrogens in oral contraceptives: historical perspectives. Johns Hopkins Med J (1982) 0.78

Metabolic balance studies with norethynodrel and chlormadinone acetate. Am J Obstet Gynecol (1967) 0.77

Metabolism of 11-beta-hydroxyandrostenedione, adrenosterone and hydrocortisone to urinary 11-oxy 17-ketosteroids. J Clin Endocrinol Metab (1969) 0.77

Management of menopause when estrogen cannot be used. Drugs (1990) 0.77

Relative rates of 2- and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett (1982) 0.77

Diagnosis of menopause: ratios of FSH/LH? Fertil Steril (1996) 0.76

The history of steroidal contraceptive development: the estrogens. Perspect Biol Med (1993) 0.76

When is it safe to switch from oral contraceptives to hormonal replacement therapy? Contraception (1995) 0.76

Radioimmunoassay of plasma androstenedione, testosterone and 11beta-hydroxyandrostenedione after chromatography on Lipidex-5000 (hydroxyalkoxypropyl Sephadex). J Steroid Biochem (1978) 0.76

Biosynthesis of 11 -hydroxyandrostenedione by human and baboon adrenals. Acta Endocrinol (Copenh) (1973) 0.76

How the oral contraceptives came to be developed. JAMA (1974) 0.76

Synthesis of new steroid haptens for radioimmunoassay--VI. 3-O-Carboxymethyl ether derivatives of equine estrogens. Highly specific antisera for measurement of equilin and 17 alpha-dihydroequilin in plasma. J Steroid Biochem (1980) 0.76

Cardiovascular disease in women. Circulation (1994) 0.75

Luteal phase deficiency. Fertil Steril (1989) 0.75

Plasma gonadotropin-releasing hormone profiles after intravenous and subcutaneous bolus injection in thin and obese women. Obstet Gynecol (1988) 0.75

Oral contraceptive use and breast cancer. Br J Cancer (1987) 0.75

Specific antisera suitable for solid-phase radioimmunoassay of 11beta-hydroxyandrost-4-ene-3,17-dione. Steroids (1974) 0.75

Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles. Fertil Steril (1978) 0.75

Practical determination of total plasma cortisol by use of competitive protein binding. Clin Chem (1974) 0.75

Normal values for blood constituents of the baboon. II. Lab Anim Sci (1972) 0.75

A metabolic balance study of the effects of an oral steroid contraceptive on weight and body composition. Contraception (1972) 0.75

Biosynthesis of allo-3-beta-tetrahydrocortisol (Reichstein's substance V) by an adrenal adenoma. J Clin Endocrinol Metab (1969) 0.75

Thyroid responsiveness in Gravesian ophthalmopathy. Arch Intern Med (1972) 0.75

The metabolism and effects of contraceptive steroids in primates. Acta Endocrinol Suppl (Copenh) (1972) 0.75

Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles. Fertil Steril (1978) 0.75

[Mechanism of action of cuneiform resection of the ovaries in a patient with Stein-Leventhal syndrome: effect of gonadotropin secretion]. Rev Invest Clin (1973) 0.75

Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Am J Obstet Gynecol (1975) 0.75

Ovarian morphologyy after prolonged use of steroid contraceptive agents. Contraception (1972) 0.75

Antiovulatory activity of synthetic corticoids. J Clin Endocrinol Metab (1975) 0.75

Modern laboratory diagnosis of thyroid disease. Tex Med (1976) 0.75

Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles. Fertil Steril (1977) 0.75

The baboon. Clinical chemistry. Primates Med (1973) 0.75

Synthesis of 17beta-D-glucopyranosiduronic acid of 17alpha-ethynylestradiol. J Steroid Biochem (1978) 0.75

Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol). Fertil Steril (1969) 0.75

Extraction of steroid conjugates from aqueous solutions. Anal Biochem (1969) 0.75

Clinical investigation: a guide to its evaluation. Am J Obstet Gynecol (1969) 0.75

Steroid biosynthesis in a feminizing adrenal carcinoma. J Clin Endocrinol Metab (1969) 0.75

Interpretation of data by the clinician. Int J Gynaecol Obstet (1979) 0.75

Technologic revolution in contraception. Int J Gynaecol Obstet (1979) 0.75

Natural family planning: suitability of the CUE method for defining the time of ovulation. Contraception (1997) 0.75

Absence of capillary microangiopathy in oral contraceptive users with glucose intolerance. Obstet Gynecol (1978) 0.75

Metabolism in vitro of androstenedione and dehydroepiandrosterone by normal ovarian tissue. Biochim Biophys Acta (1969) 0.75

The interface of animal and clinical pharmacology. J Steroid Biochem (1975) 0.75

The effect of formalin and the duration of acid hydrolysis on free and conjugated urinary 17-ketosteroids. Clin Chem (1968) 0.75

Antisera for radioimmunoassay of 17alpha-ethynylestradiol and mestranol. Steroids (1974) 0.75

Isolation of 17 alpha-ethynyl steroids by column chromatography on silver impregnated Florisil. Steroids (1969) 0.75

[In defense of the pill]. Ginecol Obstet Mex (1978) 0.75

Large-scale study of an oral contraceptive. Fertil Steril (1969) 0.75

The effect of testosterone and other adrenal steroids on PMS-induced ovulation in the immature rat. Neuroendocrinology (1975) 0.75

Effect of timing and quantity of estrogen on gonadotrophin-induced ovulation in immature rats. Endocrinology (1970) 0.75

Letter: Postmenopausal estrogen therapy. JAMA (1974) 0.75

Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol. Steroids (1975) 0.75

Seven years of clinical experience with a sequential oral contraceptive. Int J Fertil (1969) 0.75

Comparative studies of the ethynyl estrogens used in oral contraceptives. I. Endometrial response. Am J Obstet Gynecol (1975) 0.75